United States · FDA National Drug Code directory
Nazal
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 49873-057_0bde79a3-26b2-e0d2-e063-6294a90ac663
- Product NDC
- 49873-057
- Form
- LIQUID
- Composition / generic term
- Naphazoline hydrochloride
- Labeler
- Sato Pharmaceutical Co., Ltd.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 19900611
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPHAZOLINE HYDROCHLORIDE — 50 mg/100mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (49873-057-01) / 30 mL in 1 BOTTLE · 49873-057-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →